Guideline on diagnosis and treatment of Langerhans cell histiocytosis in children

Title: Guideline on diagnosis and treatment of Langerhans cell histiocytosis in children
Edition: Original
Classification: Standard guideline
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users:
Evidence classification method: Oxford Unversity, Center for Evidence-Based Medicine
Development unit: Beijing Children’s Hospital, Capital Medical University
Registration time: 2022-01-11
Registration number: IPGRP-2022CN029
Purpose of the guideline: